Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the quarterly period ended June 30, 2003
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from           to

Commission file number 000-29273

QUOVADX, INC.

(Exact name of registrant as specified in its charter)
     
Delaware   85-0373486
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

6400 S. Fiddler’s Green Circle, Suite 1000, Englewood, Colorado 80111

(Address of principal executive offices)

(303) 488-2019

(Registrant’s telephone number)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

      Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).     Yes þ          No o

      At August 4, 2003, 30,537,391 shares of common stock were outstanding.




TABLE OF CONTENTS

PART I FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS
RISK FACTORS
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EX-31.1 Certification of Chief Executive Officer
EX-31.2 Certification of Chief Financial Officer
EX-32.1 Certification of Chief Executive Officer
EX-32.2 Certification of Chief Financial Officer


Table of Contents

QUOVADX, INC.

TABLE OF CONTENTS

           
Page No.

Part I — Financial Information
       
 
Item 1 — Condensed Consolidated Financial Statements:
       
Condensed Consolidated Balance Sheets as of June 30, 2003 and December 31, 2002
    3  
Condensed Consolidated Statements of Operations for the three months and six months ended June 30, 2003 and 2002
    4  
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2003 and 2002
    5  
Notes to Condensed Consolidated Financial Statements
    6  
 
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations
    9  
 
Item 3 — Quantitative and Qualitative Disclosures About Market Risk
    19  
 
Item 4 — Controls and Procedures
    19  
Part II — Other Information
       
 
Item 1 — Legal Proceedings
    20  
 
Item 2 — Changes in Securities and Use of Proceeds
    21  
 
Item 3 — Defaults Upon Senior Securities
    21  
 
Item 4 — Submission of Matters to a Vote of Security Holders
    21  
 
Item 5 — Other Information
    21  
 
Item 6 — Exhibits and Reports on Form 8-K
    21  
Signatures
    22  

2


Table of Contents

PART I FINANCIAL INFORMATION

 
Item 1.      Condensed Consolidated Financial Statements

QUOVADX, INC.

 
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share amounts)
(Unaudited)
                       
June 30, December 31,
2003 2002


ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 36,600     $ 31,244  
 
Short-term investments
    5,491       16,377  
 
Accounts receivable, net of allowance of $2,037 and $2,370, respectively
    8,762       10,980  
 
Unbilled accounts receivable
    8,037       5,571  
 
Other current assets
    3,506       1,904  
     
     
 
   
Total current assets
    62,396       66,076  
Property and equipment, net
    4,680       5,326  
Software, net
    18,901       20,465  
Other intangible assets, net
    5,502       6,266  
Other assets
    6,095       6,476  
     
     
 
   
Total assets
  $ 97,574     $ 104,609  
     
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
 
Current liabilities:
               
 
Accounts payable
  $ 1,448     $ 1,288  
 
Accrued liabilities
    5,512       6,007  
 
Unearned revenue
    6,668       8,241  
     
     
 
   
Total current liabilities
    13,628       15,536  
Deferred revenue
          2,125  
     
     
 
   
Total liabilities
    13,628       17,661  
     
     
 
Commitments and contingencies
               
Stockholders’ equity:
               
 
Preferred stock, $.01 par value, 5,000,000 shares authorized; no shares issued and outstanding
           
 
Common stock, $.01 par value; 100,000,000 authorized and 30,518,858 and 30,176,159 shares issued and outstanding
    305       302  
 
Additional paid-in capital
    227,105       226,685  
 
Accumulated deficit
    (143,464 )     (140,039 )
     
     
 
   
Total stockholders’ equity
    83,946       86,948  
     
     
 
     
Total liabilities and stockholders’ equity
  $ 97,574     $ 104,609  
     
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements

3


Table of Contents

QUOVADX, INC.

 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except for per share amounts)
(Unaudited)
                                       
Three Months Ended Six Months Ended
June 30, June 30,


2003 2002 2003 2002




Revenue:
                               
 
License
  $ 7,242     $ 1,727     $ 12,582     $ 5,367  
 
Services
    4,317       6,434       8,871       13,462  
 
Recurring
    7,785       7,113       15,324       14,214  
     
     
     
     
 
   
Total revenue
    19,344       15,274       36,777       33,043  
     
     
     
     
 
Cost of revenue:
                               
 
License
    2,158       1,415       5,086       2,498  
 
Services
    3,129       4,682       6,132       8,519  
 
Recurring
    5,164       4,426       10,053       9,431  
     
     
     
     
 
   
Total cost of revenue
    10,451       10,523       21,271       20,448  
     
     
     
     
 
     
Gross profit
    8,893       4,751       15,506       12,595  
     
     
     
     
 
Operating expenses:
                               
 
Sales and marketing
    4,052       3,479       7,894       6,215  
 
General and administrative
    3,146       3,247       6,176       6,599  
 
Research and development
    2,246       1,777       4,493       3,209  
 
Amortization of acquired intangibles
    307       553       764       1,123  
     
     
     
     
 
   
Total operating expenses
    9,751       9,056       19,327       17,146  
     
     
     
     
 
Loss from operations
    (858 )     (4,305 )     (3,821 )     (4,551 )
 
Gain on sale of assets
                      87  
 
Interest income, net
    207       292       396       553  
     
     
     
     
 
Net loss
  $ (651 )   $ (4,013 )   $ (3,425 )   $ (3,911 )
     
     
     
     
 
Net loss per common share — basic and diluted
  $ (0.02 )   $ (0.13 )   $ (0.11 )   $ (0.13 )
     
     
     
     
 
Weighted average common shares outstanding — basic and diluted
    30,406       30,013       30,297       29,870  
     
     
     
     
 

The accompanying notes are an integral part of these condensed consolidated financial statements

4


Table of Contents

QUOVADX, INC.

 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
                       
Six Months Ended
June 30,

2003 2002


Cash flows from operating activities
               
Net loss
  $ (3,425 )   $ (3,911 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
 
Depreciation and amortization
    4,446       4,273  
 
Amortization of acquired intangibles
    764       1,123  
 
Gain on sale of assets
          (87 )
 
Amortization of unearned compensation
          119  
 
Bad debt expense
    477        
 
Change in assets and liabilities:
               
   
Accounts receivable
    1,741       (2,718 )
   
Unbilled accounts receivable
    (2,466 )     1,063  
   
Other assets
    (1,220 )     (1,167 )
   
Accounts payable
    160       (820 )
   
Accrued liabilities
    (496 )     (3,982 )
   
Unearned and deferred revenue
    (3,698 )     243  
     
     
 
     
Net cash used in operating activities
    (3,717 )     (5,864 )
     
     
 
Cash flows from investing activities
               
 
Purchase of property and equipment
    (569 )     (774 )
 
Capitalized software
    (1,667 )     (2,075 )
 
Sales of short-term investments
    15,054       11,625  
 
Purchases of short-term investments
    (4,168 )     (4,000 )
 
Business acquisitions, net of acquired cash
          (1,633 )
     
     
 
     
Net cash provided by investing activities
    8,650       3,143  
     
     
 
Cash flows from financing activities
               
 
Proceeds from issuance of common stock
    423       857  
     
     
 
     
Net cash provided by financing activities
    423       857  
     
     
 
Net increase (decrease) in cash and cash equivalents
    5,356       (1,864 )
Cash and cash equivalents at beginning of period
    31,244       25,383  
     
     
 
Cash and cash equivalents at end of period
  $ 36,600     $ 23,519  
     
     
 
Supplemental disclosure of non-cash financing transactions
               
 
Issuance of common stock in business acquisition
  $     $ 920  
 
Receipt of stock in asset sale
          662  

The accompanying notes are an integral part of these condensed consolidated financial statements

5


Table of Contents

QUOVADX, INC.

 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
1. Interim Financial Statements

      The accompanying condensed consolidated financial statements of Quovadx, Inc. (“Quovadx,” the “Company,” “we” or “us”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. However, we believe that the disclosures are adequate to make the information presented not misleading. The unaudited financial statements have been prepared on the same basis as our annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for a fair presentation in accordance with accounting principles generally accepted in the United States. The results for the three and six months ended June 30, 2003 are not necessarily indicative of the results expected for the full year. These financial statements should be read in conjunction with the audited financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2002.

      Reclassifications. Certain prior year information has been reclassified to conform with the current year presentation.

 
2. Net Loss per Common Share

      Net loss per common share (“EPS”) is calculated in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 128, “Earnings per Share.” Under the provisions of SFAS No. 128, basic EPS is computed by dividing the net income for the period by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution that could occur if stock options were exercised, resulting in the issuance of common stock that would share in the earnings of the Company. Potential dilution of the stock options exercisable into common stock is computed using the treasury stock method based on the average fair market value of the stock. In periods where the Company has a net loss the effect of common stock equivalents is excluded from the computation of diluted EPS since their effect would decrease the loss per share. The diluted weighted average common shares calculation for the three and six months ended June 30, 2003 and 2002 excludes 521,996 and 1,824,561 options, respectively, to purchase common stock because their effect would have been anti-dilutive.

      The following table sets forth the computation of the numerators and denominators in the basic and diluted net loss per common share calculations for the periods indicated (in thousands):

                                   
Three Months Ended Six Months Ended
June 30, June 30,


2003 2002 2003 2002




Numerator:
                               
 
Net loss available to common stockholders
  $ (651 )   $ (4,013 )   $ (3,425 )   $ (3,911 )
     
     
     
     
 
Denominator:
                               
 
Weighted average common shares outstanding — basic
    30,406       30,013       30,297       29,870  
 
Effect of dilutive securities:
                               
 
Employee stock options
                       
     
     
     
     
 
 
Weighed average common shares outstanding — diluted
    30,406       30,013       30,297       29,870  
     
     
     
     
 

6


Table of Contents

QUOVADX, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
3. Segment Information

      Segment information has been prepared in accordance with SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” The Company defines operating segments as components of an enterprise for which discrete financial information is available and is reviewed regularly by the chief operating decision-maker or decision-making group, to evaluate performance and make operating decisions. The chief operating decision-making group reviews the revenue and margin by the nature of the services provided and reviews the overall results of the Company. Accounting policies of the segments are the same as those described in the summary of significant accounting policies in the company’s annual report on form 10K for the year ended December 31, 2002.

      The Company operates in three segments: professional services, software licenses and recurring revenue. The professional services segment includes revenue generated from software implementation, development and integration. The software license segment includes revenue from perpetual software license sales and software subscriptions. The recurring revenue segment includes revenue generated from outsourcing, hosting, maintenance, transactions, and other recurring services.

      Following is a breakout by segment.

                                           
Software Professional Consolidated
License Services Recurring Other Total





(In thousands)
Three Months Ended June 30,